Neurothrombectomy Devices Market Growth & Trends
The global neurothrombectomy devices market size is anticipated to reach USD 864.02 million by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.4% during the forecast period. Increasing incidence of acute ischemic stroke, such as intracerebral hemorrhage and subarachnoid hemorrhage stroke is anticipated to boost the growth. For instance, according to the Stroke Alliance for Europe, total number of stroke in Europe will increase by 34% from 2015 to 2035.
Technological advancements play a crucial role in fueling the market growth. For instance, Medtronic’s Solitaire Platinum Revascularization Neurothrombectomy Device, which is a pushwire attached nitinol scaffolding design. This device is designed to reduce around 70% of stroke-related disability and to improve the functional outcome at 90 days in patients suffering a large vessel occlusion.
The hospital segment led the neurothrombectomy devices market in 2018 owing to high prevalence and rising awareness regarding neurothrombectomy. In addition, as compare to clinics, hospitals remain at the top priority for patients suffering from acute ischemic disease as this disease have to be treated within 8 hours of onset of the symptoms. However, Ambulatory Surgical Centers (ASCs) is anticipated to be the fastest growing segment over the forecast period, attributed to shorter waiting time that ASCs provide to the patients and increasing number of ASC facilities.
Request a free sample copy or view report summary: Neurothrombectomy Devices Market Report
Neurothrombectomy Devices Market Report Highlights
- Clot retrievers segment led the neurothrombectomy devices market in 2018 and is anticipated to register the highest CAGR over the forecast period, attributed to increasing number of patients suffering from acute ischemic stroke due to large vessel occlusion
- Europe held the highest market share in terms of revenue in 2018 and is expected to expand at the highest CAGR over the forecast period owing to the presence of well-developed healthcare facilities and favorable reimbursement policies as well as the rise in number of supportive government awareness programs, and neurothrombectomy device approvals.
- The key players opt for technologically advanced products and undertake various initiatives such as partnerships, new product development, and collaborations to gain the competitive advantage in the market. For instance, in 2019, Stryker announced the launch of its New Sonopet iQ ultrasonic aspiration system which increases speed and precision to enhanced ease of use.
Neurothrombectomy Devices Market Segmentation
Grand View Research has segmented the global neurothrombectomy devices market on the basis of product, end use, and region:
Neurothrombectomy Devices Product Outlook (Revenue, USD Million, 2015 - 2026)
- Clot Retriever
- Aspiration/Suction Devices
- Vascular snares
Neurothrombectomy Devices End Use Outlook (Revenue, USD Million, 2015 - 2026)
- Hospitals
- Emergency Clinics
- Ambulatory Surgical Centers
Neurothrombectomy Devices Regional Outlook (Revenue, USD Million, 2015 - 2026)
- North America
- US.
- Canada
- Europe
- Germany
- UK.
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment